WiseApp for Spanish Speakers Living With HIV
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorColumbia University
About this trial
This study aims to conduct a 12-month randomized controlled trial to adapt the mobile app, WiseApp, and a smart pill dispenser for Spanish-speaking people living with HIV (PLWH) in the New York City (NYC) area and La Romana, Dominican Republic (DR). The study will assess the efficacy and sustainability of WiseApp as well as identify barriers with its widespread use among Spanish speakers. With disproportionately high rates of HIV in the New York City area and the Dominican Republic, this project seeks to identify distinct contextual factors related to Spanish speaking people living with HIV and increase the likelihood of engagement with technology and improvements in clinical outcomes.
Eligibility criteria
Qualifiers
Able to speak, read, and write in Spanish;
Aged ≥18 years;
Willing to participate in any assigned arm of the intervention;
Have an HIV-1 RNA level >50 copies/mL;
Disqualifiers
Reside in a nursing home, prison, and/or receiving in-patient psychiatric care at time of enrollment;
Terminal illness with life expectancy <6 months;
Planning to move out of the area in the next 12 months;
A cognitive state minimum score measured by the Mini-Mental State Examination (MMSE) to ensure participants are oriented to time and place.
Trial design
Treatments tested in this trial
- CleverCap
Treatment groups
248 Participants
are divided into 2 treatment groupsSponsors and collaborators
Columbia University
Lead sponsor
Clínica de Familia La Romana, Dominican Republic
Collaborator
Source ClinicalTrials.gov